hb a1c การใช้

• The phase III study DURATION-1 published in 2008 showed the once weekly formulation resulted in a greater Hb A1c decline and more patients reaching Hb A1c targets compared to twice-daily Byetta.
• The phase III study DURATION-1 published in 2008 showed the once weekly formulation resulted in a greater Hb A1c decline and more patients reaching Hb A1c targets compared to twice-daily Byetta.
• In older patients, clinical practice guidelines by the American Geriatrics Society states " for frail older adults, persons with life expectancy of less than 5 years, and others in whom the risks of intensive glycemic control appear to outweigh the benefits, a less stringent target such as Hb A1c of 8 % is appropriate ".